PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma
Clinical Neuropathology · 2011
DOI: 10.5414/np300371 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Neuropathology, 2011. Verfasst von T Asklund und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Sciences and Oncology, Norrlands University Hospital, Umeå, Sweden. thomas.asklund@onkologi.umu.se. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Sciences and Oncology, Norrlands University Hospital, Umeå, Sweden. thomas.asklund@onkologi.umu.se
Zitieren
APA
Asklund, T., Danfors, T., & Henriksson, R. (2011). PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma. Clinical Neuropathology. https://doi.org/10.5414/np300371
Vancouver
Asklund T, Danfors T, Henriksson R. PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma. Clinical Neuropathology. 2011. doi:10.5414/np300371
BibTeX
@article{Asklund2011,
author = {Asklund, T and Danfors, T and Henriksson, R},
title = {PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma},
journal = {Clinical Neuropathology},
year = {2011},
doi = {10.5414/np300371}
}
EUVIMED